Skip to content

Best Practice Recommendations for Canadian Harm Reduction Programs

Cover of Best Practice Recommendations

Drug use practices that can lead to transmission of HIV, HCV, and other infections are pressing issues affecting communities throughout Canada. To stay current with emerging evidence and ensure that people have access to high-quality services that help prevent HIV and HCV transmission, best practice recommendations must undergo review and update. A Canada-wide team of researchers, service providers, policy makers and people with lived experience have developed, through extensive literature review and synthesis, an updated and comprehensive set of best practice recommendations.

These recommendations, updated in 2021, will help service providers develop, redesign and evaluate programs for people who use drugs and who are at risk for HIV, hepatitis C, hepatitis B, and other harms.